CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2015 - 2026)
CRISPR Therapeutics AG (CRSP) reported Exchange Rate Effect of -$32000.0 for Q1 2026, down 178.05% on a YoY basis from $41000.0 in Q1 2025, and down 3300.0% sequentially from $1000.0 in Q4 2025.
CRISPR Therapeutics AG (CRSP) Exchange Rate Effect (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 12 years of Exchange Rate Effect data on file, last reported at -$32000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 178.05% year-over-year to -$32000.0; the trailing twelve-month figure through Mar 2026 stood at $22000.0 (down 29.03% YoY), and the FY2025 full-year result was $95000.0, up 552.38% from the prior year.
- Exchange Rate Effect retreated to -$32000.0 in Q1 2026, from $1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $115000.0 in Q4 2022 to a low of -$100000.0 in Q3 2022.
- A 5-year average of $2058.8 and a median of $1000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect tumbled 1460.0% in 2022 and soared 3900.0% in 2025, its largest moves.
- Tracing CRSP's Exchange Rate Effect over 5 years: stood at $115000.0 in 2022, then sank by 46.96% to $61000.0 in 2023, then slumped by 242.62% to -$87000.0 in 2024, then jumped by 101.15% to $1000.0 in 2025, then tumbled by 3300.0% to -$32000.0 in 2026.
- Business Quant data shows CRSP's Exchange Rate Effect at -$32000.0 in Q1 2026, $1000.0 in Q4 2025, and -$27000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CRISPR Therapeutics AG | 4.57 Bn | 2.12 Bn | - | -32,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32,000.00 |
| Mar 31, 2026 | -32,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Sep 30, 2025 | -27,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Dec 31, 2023 | 61,000.00 |